M1 stage subdivisions based on 18 F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma.
Hui-Zhi QiuXu ZhangSai-Lan LiuXue-Song SunYi-Wen MoHuan-Xin LinZi-Jian LuJia GuoLin-Quan TangHai-Qiang MaiLi-Ting LiuLing GuoPublished in: Therapeutic advances in medical oncology (2022)
The PPS-based RPA stratification model could identify suitable candidates for LRRT. Patients with stage M1a disease could benefit from LRRT.